Published on Web 08/25/2010
Controlling a Structural Branch Point in Ergot Alkaloid Biosynthesis
†
‡
,‡
,†
Johnathan Z. Cheng, Christine M. Coyle, Daniel G. Panaccione,* and Sarah E. O’Connor*
Massachusetts Institute of Technology, Department of Chemistry, 77 Massachusetts AVenue,
Cambridge, Massachusetts 02139, and West Virginia UniVersity, DiVision of Plant & Soil Sciences, Morgantown,
West Virginia 26506
Received June 30, 2010; E-mail: Dan.Panaccione@mail.wvu.edu; soc@mit.edu
a
Scheme 1
Abstract: The ergot alkaloids are a diverse class of fungal-
derived indole alkaloid natural products with potent pharmacologi-
cal activities. The biosynthetic intermediate chanoclavine-I alde-
hyde 1 represents a branch point in ergot biosynthesis. Ergot
alkaloids festuclavine 2 and agroclavine 3 derive from alternate
enzymatic pathways originating from the common biosynthetic
precursor chanoclavine-I aldehyde 1. Here we show that while
the Old Yellow Enzyme homologue EasA from the ergot biosyn-
thetic gene cluster of Aspergillus fumigatus acts on chanoclavine-I
aldehyde 1 to yield festuclavine 2, EasA from Neotyphodium lolii,
in contrast, produces agroclavine 3. Mutational analysis suggests
a mechanistic rationale for the switch in activity that controls this
critical branch point of ergot alkaloid biosynthesis.
a
(
A) Reduction of C8-C9 alkene by EasA_Af leads to festuclavine 2.
(
B) EasA_Nl leads to formation of agroclavine 3.
The ergot alkaloids are a diverse class of fungal-derived indole
alkaloid natural products with potent pharmacological activities. The
biosynthetic intermediate chanoclavine-I aldehyde 1 can be enzymati-
cally converted into festuclavine 2, which is further derivatized to form
1
isomerization step required for the conversion of chanoclavine-I
2,4
aldehyde 1 into agroclavine 3. Mutational analysis suggests a
mechanistic rationale for the switch in activity of EasA- from
reductase in A. fumigatus to isomerase in N. lolii- that controls this
critical branch point of ergot alkaloid biosynthesis.
alkaloids such as the fumigaclavines in Aspergillus fumigatus (Scheme
1
1
). Alternatively, in certain fungal species such as ClaViceps purpurea
3
Based on previous analyses and homology of EasA with Old
and Neotyphodium lolii, chanoclavine-I aldehyde 1 is converted to
Yellow Enzyme, a flavoenzyme that typically reduces the alkene
agroclavine 3, which goes on to form lysergic acid-derived ergot
5
1
of an R, ꢀ unsaturated carbonyl moiety, the role of EasA in fungal
alkaloids such as ergopeptines. Festuclavine 2 and agroclavine 3 differ
producers of festuclavine 2 is clear: reduction of the C8-C9 double
bond of chanoclavine-I aldehyde 1 (Scheme 1A). However, fungal
producers of agroclavine 3, which retains the C8-C9 alkene, also
only by the degree of unsaturation in the D ring (Scheme 1). Although
chanoclavine-I aldehyde 1 had been proposed as an ergot alkaloid
2
biosynthetic intermediate many years ago, the enzyme-catalyzed
1
contain an EasA homologue in the ergot gene clusters. EasA
mechanism of D ring formation has remained elusive. Recently, we
and others have reported that a homologue of Old Yellow Enzyme
from A. fumigatus, EasA_Af, reduces the alkene of the chanoclavine-I
therefore likely plays a different role in this biosynthetic pathway.
Notably, an A. fumigatus (a festuclavine 2 producer) ∆easA
disruption strain transformed with easA from C. purpurea (an
3
aldehyde R, ꢀ unsaturated carbonyl moiety (C8-C9, Scheme 1A).
6
agroclavine 3 producer) yielded agroclavine 3 derived alkaloids.
This reduction facilitates an intramolecular reaction between the
aldehyde and the amine moieties to allow formation of the D ring of
festuclavine 2 (Scheme 1A). Yet it is still unclear how chanoclavine-I
aldehyde 1 is converted into agroclavine 3, which retains the C8-C9
double bond of the starting precursor, but with this alkene in the
opposite geometrical configuration. Formation of agroclavine 3 from
chanoclavine-I aldehyde 1 was investigated previously by Floss and
This experiment strongly suggests that EasA is the checkpoint that
controls whether chanoclavine-I aldehyde 1 is converted to festu-
clavine 2 or agroclavine 3. To gather mechanistic data to test this
hypothesis, an in Vitro assay for agroclavine 3 producing EasA
enzymes is required. Unfortunately, when EasA from C. purpurea
was heterologously expressed in E. coli, the resulting protein was
catalytically inactive with chanoclavine-I aldehyde 1 and lacked
the expected flavin cofactor as evidenced by UV-vis spectroscopy.
However, EasA from another agroclavine 3 producer N. lolii
2,4
colleagues in whole-cell precursor feeding studies. Results of these
studies not only clearly demonstrated precursor-product relationships
but also raised unanswered questions about the enzymes and mech-
anisms involved. One particularly puzzling step implicated a cis-trans
isomerization involving intermolecular transfer of a hydrogen between
successive substrate molecules. Here we show that an EasA homologue
from the ergot biosynthetic gene cluster of N. lolii, EasA_Nl acts on
chanoclavine-I aldehyde 1 to yield agroclavine 3 rather than festucla-
vine 2, therefore supporting the previously proposed cis-trans
(
EasA_Nl) could be expressed as an active, holo-enzyme from E.
coli (Supporting Information, SI).
We compared the products of EasA_Af and EasA_Nl when
7a
incubated with chanoclavine-I aldehyde 1 substrate in the presence
of NADPH-dependent oxidoreductase EasG (A. fumigatus). Recent
work by Wallwey et al. has revealed that EasG reduces the cyclic
iminium product generated by EasA_Af to form festuclavine 2
3
b
†
(Scheme 1A). EasG, which is present in all ergot biosynthetic
Massachusetts Institute of Technology.
West Virginia University.
‡
gene clusters, likely plays a similar role in agroclavine 3 biosyn-
10.1021/ja105785p 2010 American Chemical Society
J. AM. CHEM. SOC. 2010, 132, 12835–12837 9 12835